Literature DB >> 14511618

Pseudomyxoma peritonei: a review of 62 cases.

S van Ruth1, Y I Z Acherman, M J van de Vijver, A A M Hart, V J Verwaal, F A N Zoetmulder.   

Abstract

AIM: Pseudomyxoma peritonei (PMP) is a rare disease characterized by the abundance of mucus in the abdomen without extra-peritoneal growth.
METHODS: Our patients with PMP have been treated with cytoreduction and hyperthermic intraperitoneal chemotherapy since 1996. The clinical and histopathological features of PMP and the relation of these features with disease-free interval and survival were assessed.
RESULTS: Sixty-two patients with PMP (24 M/38 F) were studied. Adenomatous mucosal changes were present in 31 patients. In females, the ovaries were normal in 5 patients and pseudomyxoma ovarii was present in 20 patients. Patients with minimal atypia and with 1% focal proliferation or less (n=38) had a better survival (p=0.0008) than those with more focal proliferation (n=14).
CONCLUSION: In most patients with PMP the appendix is affected; in females the ovaries are usually also involved. Focal proliferation appears to be a prognostic factor.

Entities:  

Mesh:

Year:  2003        PMID: 14511618     DOI: 10.1016/s0748-7983(03)00149-5

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  29 in total

1.  High-quality results of cytoreductive surgery and heated intraperitoneal chemotherapy perfusion for carcinomatosis at a low volume institution.

Authors:  Swaroop R Bommareddi; Vlad V Simianu; Lisa V Mann; Gary N Mann
Journal:  J Surg Oncol       Date:  2015-08-14       Impact factor: 3.454

2.  Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed.

Authors:  Irvin M Modlin; Mark Kidd; Igor Latich; Michelle N Zikusoka; Geeta N Eick; Shrikant M Mane; Robert L Camp
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

3.  The importance of gender in patients with peritoneal metastases of appendiceal origin treated by cytoreduction and intraperitoneal chemotherapy: an analysis of 257 consecutive patients from an Australian centre.

Authors:  Lawson Ung; Terence C Chua; David L Morris
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-21       Impact factor: 4.553

4.  Jelly from the belly button: What's the diagnosis?

Authors:  Herbert L Fred; Gabriel M Aisenberg; Agnes M Guthrie; Hendrik A van Dijk
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-05-10

5.  Pseudomyxoma peritonei.

Authors:  T M Anoop; Teny M John; N Fukunaga
Journal:  Indian J Surg       Date:  2010-10-20       Impact factor: 0.656

6.  Histological origin of pseudomyxoma peritonei in Chinese women: clinicopathology and immunohistochemistry.

Authors:  Ai-Tao Guo; Xin Song; Li-Xin Wei; Po Zhao
Journal:  World J Gastroenterol       Date:  2011-08-14       Impact factor: 5.742

7.  Pseudomyxoma peritonei: a rare tumour mimicking primary ovarian neoplasia.

Authors:  Cátia Filipa Martins; Sara Costa; Pedro Guedes; Ana Filipa Rafael
Journal:  BMJ Case Rep       Date:  2015-03-05

8.  Pseudomyxoma extraperitonei: a rare presentation of a rare tumour.

Authors:  Carmina Diaz-Zorrilla; Antonio Ramos-De la Medina; Peter Grube-Pagola; Alfredo Ramirez-Gutierrez de Velasco
Journal:  BMJ Case Rep       Date:  2013-02-04

9.  Appendiceal mucocele. a retrospective analysis of 19 cases.

Authors:  B Papaziogas; I Koutelidakis; P Tsiaousis; O C Goula; S Lakis; S Atmatzidis; J Makris; G Paraskevas; K Atmatzidis
Journal:  J Gastrointest Cancer       Date:  2007

10.  Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4).

Authors:  Chin-Fan Chen; Che-Jen Huang; Wan-Yi Kang; Jan-Sing Hsieh
Journal:  World J Surg Oncol       Date:  2008-11-11       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.